Aurora IV and Wellness has settled a lawsuit with the state over allegations of using unapproved weight loss drugs, resulting in the clinic's closure and financial penalties for its owners.

Preliminary BRIUMVI U.S. fourth quarter and full year 2025 net product revenue of approximately $182 million and $594 million, respectively Full Year 2026 target total global revenue of approximately ...

Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to focus on its rare-disease pipeline, which is the subject of ongoing BD ...

When you get IV vitamin infusions outside of a medical setting, it’s difficult to know what’s going into your body and how it ...

Alabama Attorney General Steve Marshall shut down a Cullman IV clinic after allegations it gave patients unsafe, ...

Reported $4.15 billion (YoY growth of +90%) in preliminary* full-year 2025 global product net sales, inclusive of $1.29 billion in fourth quarter sales ...

A single dose of intravenous (IV) iron dextran is the cost-effective treatment for women with heavy menstrual bleeding and ...

NICE has backed NHS use of natalizumab, a key treatment option that is safe for use in pregnancy, for more patients with ...

NICE has backed NHS use of natalizumab, a key treatment option that is safe for use in pregnancy, for more patients with ...

1 Department of Neurology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China 2 School of Nursing, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China ...

Safety in pediatric sedation relies on strict guidelines and monitoring, so let's learn how providers utilize pharmacological ...